Physician
America Cares Trust, INC
America Cares Trust, INC was paid $9.12M by Medicaid between Jan 2018 and Mar 2022, across 105 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 33% of everything it billed.
33Billing provider infoAMERICA CARES TRUST, INC
NASHVILLE, TN 37217
NASHVILLE, TN 37217
33aNPI1215364633assigned 09/30/2013
33bProvider typePediatrics Physician
28Total paid$9.12M
24GClaims444,830
24DCodes billed105
24AFirst – last monthJan 2018 – Mar 2022
Compared with peers
Next to other Pediatrics Physician providers in Tennessee
Rank by total paid#12 of 333
Median peer was paid$139K
This provider vs. median65×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 230,654 | $4.80M | |
| 2019 | 82,802 | $2.16M | |
| 2020 | 94,164 | $1.54M | |
| 2021 | 32,834 | $502K | |
| 2022 | 4,376 | $110K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 33% | 70,018 | 50,977 | $2.97M |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 14% | 19,748 | 13,300 | $1.29M |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 11% | 13,788 | 9,040 | $979K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 9.0% | 12,663 | 9,033 | $818K |
| 96160 | 5.7% | 64,072 | 36,800 | $517K | |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 5.3% | 7,692 | 5,652 | $480K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 4.3% | 6,859 | 4,833 | $395K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 3.0% | 10,110 | 7,477 | $271K |
| 92551 | 2.9% | 37,339 | 24,406 | $261K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 2.5% | 30,298 | 18,130 | $230K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 2.3% | 10,116 | 6,790 | $210K |
| 96127 | 1.9% | 53,954 | 23,297 | $170K |
93 more codes
| 99173 | 1.1% | 41,644 | $99K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 6,742 | $50K |
| 90837 | Psychotherapy session, about an hour | <1% | 550 | $43K |
| 92552 | <1% | 2,119 | $41K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 661 | $40K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 2,891 | $25K |
| 99384 | <1% | 259 | $23K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 218 | $18K |
| 99383 | <1% | 253 | $14K | |
| 99381 | <1% | 237 | $12K | |
| 80061 | Lipid panel | <1% | 2,567 | $12K |
| 95165 | Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials | <1% | 211 | $12K |
| 90832 | Psychotherapy session, about 30 minutes | <1% | 293 | $11K |
| 99239 | Hospital discharge day management, more than 30 minutes | <1% | 130 | $10K |
| 96161 | <1% | 1,507 | $10K | |
| 81025 | <1% | 2,230 | $10K | |
| 99460 | <1% | 107 | $8K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 735 | $8K |
| 90791 | Psychiatric diagnostic evaluation | <1% | 111 | $8K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 194 | $7K |
| 36415 | Collection of venous blood by venipuncture | <1% | 5,360 | $7K |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 106 | $5K |
| 95004 | Percutaneous tests with allergenic extracts, immediate type reaction | <1% | 27 | $5K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 90 | $5K |
| 99401 | <1% | 277 | $5K | |
| 83655 | <1% | 725 | $5K | |
| 95117 | <1% | 860 | $4K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 245 | $4K |
| 85018 | <1% | 2,555 | $4K | |
| 36410 | <1% | 662 | $4K | |
| 36416 | <1% | 4,811 | $3K | |
| 69210 | <1% | 106 | $3K | |
| 81002 | <1% | 1,338 | $2K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 566 | $2K |
| 99174 | <1% | 264 | $2K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 794 | $2K |
| 92567 | <1% | 134 | $1K | |
| 99177 | <1% | 301 | $1K | |
| 99402 | <1% | 62 | $1K | |
| 92557 | <1% | 36 | $1K | |
| 90853 | Group psychotherapy (other than of a multiple-family group) | <1% | 50 | $1K |
| 92587 | <1% | 40 | $878.69 | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 113 | $767.14 |
| 99382 | <1% | 14 | $690.94 | |
| 99462 | <1% | 19 | $673.83 | |
| 92579 | <1% | 15 | $510.07 | |
| 90716 | <1% | 1,182 | $414.21 | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 719 | $210.34 |
| 80050 | General health panel | <1% | 184 | $209.00 |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 86 | $179.84 |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 476 | $173.30 |
| 80053 | Comprehensive metabolic panel | <1% | 439 | $169.02 |
| 82465 | <1% | 106 | $168.85 | |
| 87210 | <1% | 39 | $128.78 | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 563 | $116.80 |
| 87077 | <1% | 233 | $112.43 | |
| 81003 | <1% | 1,541 | $108.59 | |
| Q0111 | Wet mounts, including preparations of vaginal, cervical or skin specimens | <1% | 24 | $100.72 |
| 87040 | <1% | 14 | $99.04 | |
| 90680 | <1% | 1,053 | $97.43 | |
| 84439 | <1% | 434 | $79.17 | |
| 86592 | <1% | 277 | $71.37 | |
| 87088 | <1% | 26 | $50.26 | |
| 87220 | <1% | 15 | $47.46 | |
| 94760 | <1% | 15 | $31.00 | |
| 87070 | <1% | 58 | $25.00 | |
| 90744 | <1% | 663 | $20.88 | |
| 90461 | <1% | 5,477 | $15.00 | |
| 84436 | <1% | 61 | $8.00 | |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | <1% | 188 | $7.94 |
| 86803 | <1% | 134 | $0.56 | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 136 | $0.55 |
| 87632 | <1% | 77 | $0.49 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 53 | $0.32 |
| 87650 | <1% | 98 | $0.22 | |
| 87081 | <1% | 39 | $0.15 | |
| 90656 | <1% | 14 | $0.06 | |
| 90707 | <1% | 1,179 | $0.03 | |
| 90734 | <1% | 610 | $0.03 | |
| 90651 | <1% | 1,355 | $0.03 | |
| 90686 | <1% | 462 | $0.02 | |
| 90688 | <1% | 457 | $0.02 | |
| 90696 | <1% | 380 | $0.02 | |
| 90698 | <1% | 1,384 | $0.02 | |
| 90670 | <1% | 2,215 | $0.01 | |
| 90687 | <1% | 164 | $0.01 | |
| 90715 | <1% | 258 | $0.01 | |
| 90648 | 0% | 271 | $0.00 | |
| 90700 | 0% | 249 | $0.00 | |
| 90633 | 0% | 1,218 | $0.00 | |
| 90685 | 0% | 103 | $0.00 | |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 0% | 13 | $0.00 |
| 90620 | 0% | 202 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialGAW, MICHAEL (CHAIRMAN)